Fundz

Diag-Nose.io raised $2M in a seed round led by various investors to advance its RhinoMAP™ platform for respiratory diagnostics.

PRIVATEJan 30, 2025

Amount Raised

$2 Million

Round Type

Seed

BethlehemBiotechnologyHealth CareArtificial IntelligenceTherapeuticsHealth Diagnostics

Description

Diag-Nose.io, a pioneering biotech company, has closed an oversubscribed seed funding round of $2 million. The funding will support the development of its innovative RhinoMAP™ platform and ABEL Microsampler™ technology, aimed at transforming respiratory disease management.

Quick answer

Diag-Nose.io raised $2 Million in a Seed round, dated January 30, 2025. Diag-Nose.io is based in Bethlehem, Pennsylvania, United States.

How much did Diag-Nose.io raise?
Diag-Nose.io raised $2 Million in a Seed round on January 30, 2025.
What does Diag-Nose.io do?
Diag-Nose.io is a biotechnology company founded in 2020, focusing on precision diagnostic and drug discovery solutions for chronic respiratory diseases.
Where is Diag-Nose.io based and how big is it?
Diag-Nose.io is based in Bethlehem, Pennsylvania, United States. Fundz records about 7 employees.
Who are the decision-makers at Diag-Nose.io?
Fundz holds 1 contact at Diag-Nose.io. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Therapeutics and Health Diagnostics around the same time

Companies in the same sectors as Diag-Nose.io that raised within 45 days of this round, from Fundz verified event records.

  • Elea raised $4.3M (Seed) on March 12, 2025.
  • Noah Labs raised $3.1M (Seed) on February 20, 2025.
  • Newronika raised $14M (Series B) on February 13, 2025.
  • C the Signs raised $8M (Funding Round) on January 31, 2025.
  • Oxford Cancer Analytics raised $11M (Series A) on January 9, 2025.
  • Geneoscopy raised $105M (Series C) on January 8, 2025.

Who to call at Diag-Nose.io, and when

A new round usually means Diag-Nose.io is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Diag-Nose.io raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Diag-Nose.io, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Diag-Nose.io. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Diag-Nose.io

Location

Bethlehem, Pennsylvania, United States

About

Diag-Nose.io is a biotechnology company founded in 2020, focusing on precision diagnostic and drug discovery solutions for chronic respiratory diseases. Their technology integrates advanced proteomics, computational biology, and AI to enhance treatment prescription and accelerate new therapy development. The flagship platform, RhinoMAP™, aims to predict respiratory disease activity and monitor treatment efficacy. Diag-Nose.io's innovative approach seeks to transform respiratory healthcare through data-driven personalized care.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Diag-Nose.io raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Diag-Nose.io's next move

See what Strategic adds

Diag-Nose.io raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.